On Friday, Spirit AeroSystems Holdings, Inc. (NYSE:SPR)’s shares declined -2.17% to $54.95.
Spirit AeroSystems, Inc. [SPR] Global Customer Support and Services division received the Community Partner of the Year award from the Air Force Association’s Gerrity Chapter in Oklahoma City, Oklahoma. The award recognizes a single community partner who has comprising supported the Air Force Association’s Gerrity Chapter in its charter to advocate, educate, and support the United States Air Force and the Air Force family.
Spirit AeroSystems Holdings, Inc., through its auxiliaries, operates as a non-original equipment manufacturer (OEM) that designs, engineers, and manufactures large commercial aircraft structures worldwide. It operates through three segments: Fuselage Systems, Propulsion Systems, and Wing Systems.
Juno Therapeutics Inc (NASDAQ:JUNO)’s shares dropped -1.85% to $43.98.
Juno Therapeutics Inc (JUNO) might not be turning a profit yet, but that’s no problem for CEO Hans Bishop’s personal bottom line.
Bishop is the 11th highest-paid CEO in the country, according to Bloomberg’s Pay Index, a daily ranking of the 100 top-paid executives. His pay package was worth $88.2 million at the end of 2014, Bloomberg stated Thursday, in a combination of salary, stock options and restricted shares. That was worth $7.3 million before Juno’s initial public offering in December.
Juno isn’t the only biotech to show up near the top of the list. CEO pay at Santa Monica, Calif.-based Kite Pharma and Waltham, Mass.-based Radius Health Inc. topped $95 million and $33.5 million, respectively.
Juno and Kite develop immunotherapy treatments for cancer. That’s a field investors have been excited to jump into in recent years. Immunotherapy reprograms a patient’s T cells and then infuses them back into the body, giving the immune system a boost to battle the cancer.
This treatment has been heralded in recent years as a breakthrough alternative to harsher methods, such as chemotherapy and radiation.
In small clinical trials, one of Juno’s drug candidates has achieved a 90 percent remission rate in a type of blood cancer.
Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. The company develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells.
At the end of Friday’s trade, Angie’s List Inc (NASDAQ:ANGI)‘s shares dipped -0.87% to $4.58.
Summer is well under way, and that means the dulcet tones of hammers and saws will be filling the air in neighborhoods across America.
Requests for information on remodeling contractors in June, July and August account for about one-third of the total remodeling requests for the other nine months of the year. Angie’s List members conducted nearly 80,000 searches for remodeling contractors in June alone.
Angie’s List (ANGI) has gathered consumer reviews on home-related, local service companies for 20 years. In a November 2014 Angie’s List survey of more than 1,000 service providers, 62 percent said they were expecting bigger budget projects contrast to last season.
Angie’s List, Inc. operates a local services marketplace and consumer review site in the United States. The company provides marketplace to research, shop for, and purchase local services for home, health, and automotive service needs. It also allows its consumers to rate and review service providers in 253 markets. In addition, the company provides advertising services to service providers through its monthly publication and call center; and on its Website, in addition to through mobile applications. Further, its e-commerce marketplace offers consumers to purchase services directly through its marketplace from service providers.
Franco-Nevada Corporation (NYSE:FNV), ended its Friday’s trading session with 0.89% gain, and closed at $40.63.
Franco-Nevada to Release Second Quarter 2015 Results on August 10th after market close and the company will also conduct a Conference Call and Webcast on August 11th 10:00 am ET
Franco-Nevada Corporation operates as a gold-focused royalty and stream company in the United States, Canada, Latin America, and internationally. It also has interests in silver assets and polymetallic exploration prospects; platinum group metal, counting palladium; other minerals, such as base metals, iron ore, coal, and industrial and miscellaneous minerals; and oil and gas properties. As of March 25, 2015, the company had interests in 246 mineral assets and 137 oil and gas assets. Its proved reserves is 22,899 thousand barrels of oil equivalent.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
